[Role of hormone-replacement therapy for prevention of coronary artery disease in women].
The postmenopausal increase in the incidence of coronary artery disease implied a protective effect of estrogens. Nonrandomized, clinical and experimental studies have supported this notion. In the first randomized study (HERS 1998) no protective effect on prognosis of postmenopausal women with coronary artery disease was demonstrated. Also, in healthy postmenopausal women no beneficial effect of a hormone-replacement therapy on coronary events was shown (WHI-Study 2002, 2004). Therefore, hormone-replacement therapy is not recommended for prophylaxis of cardiovascular disease in healthy women or in women with documented coronary artery disease (Recommendation class I, evidence-level A). The continuation or the start of a hormone- replacement therapy is only justified for therapy of severe menopausal symptoms. Women should be informed that changes in lifestyle including not smoking, a heart healthy diet, and regular exercise are the most important measures to prevent cardiovascular diseases.
Gohlke-Bärwolf
C
C
Klinische Kardiologie I, Herzzentrum Bad Krozingen, Südring 15, 79189 Bad Krozingen, Germany. christa.gohlke-baerwolf@herzzentrum.de
von Schacky
C
C
D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000706:statistics & numerical data*; D004967:Estrogens / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015994:Incidence; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011315:Preventive Medicine / Q000379:methods / Q000706:statistics & numerical data; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016896:Treatment Outcome; D016387:Women's Health
D004967:Estrogens